References
- Martino M, Montanari M, Bruno B, et al. Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program. Expert Opin Biol Ther 2012:12:1449–1462.
- Martino M, Montanari M, Ferrara F, et al. Very low rate of re-admission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multi-center retrospective study. Biol Blood Marrow Transplant 2014;20:1026–1032.
- Summers N, Dawe U, Stewart DA. A comparison of inpatient and outpatient ASCT. Bone Marrow Transplant 2000;26:389–395.
- Fernandez-Aviles F, Carreras E, Urbano-Ispizua A, et al. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. J Clin Oncol 2006;24:4855–4861.
- Barosi G, Marchetti M, Alessandrino P, et al. A model for analysing the cost of autologous peripheral blood progenitor cell (PBPC) transplantation. Bone Marrow Transplant 1999;23:719–725.
- Mishra V, Vaaler S, Brinch L. Cost analysis of autologous peripheral blood stem cell transplantation for multiple myeloma. Clin Lab Haematol 2003;25:179–184.
- Meisenberg BR, Ferran K, Hollenbach K, et al. Reduced charges and costs associated with outpatient autologous stem cell transplantation. Bone Marrow Transplant 1998;21:927–932.
- Holbro A, Ahmad I, Cohen S, et al. Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant 2013;19:547–551.
- Faucher C, Le Corroller Soriano AG, Esterni B, et al. Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs. Bone Marrow Transplant 2012; 47:549–555.
- Westermann AM, Holtkamp MM, Linthorst GA, et al. At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies. Ann Oncol 1999;10:511–517.
- van Tiel FH, Harbers MM, Kessels AG, et al. Home care versus hospital care of patients and chemotherapy induced cytopenia. Ann Oncol 2005;16:195–205.
- Svahn BM, Remberger M, Myrbäck KE, et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002;100:4317–4324.
- Ringdén O, Remberger M, Törlén J, et al. Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital. Pediatr Transplant 2014;18:398–404.
- Bentur N. Hospital at home: what is its place in the health system? Health Policy 2001;55:71–79.